The numbers above use details from the last few years financials. There may have been a Zag Zig, where net cashflow was diverted from FY14 to FY15. I may also be nuts - so DYOR.
Equating EBITDA with net receipts excl GST => Knock $19m off their U EBITDA 15 and you get $126m adj NPBT => 87.7 adj NPAT 15 @ 30% tax => 61.4m.
Unpat target based on FY 16 guidance is about 64.7m approx. So my back of envelope calcs very roughly add up - wish I had a bit more time.
This is not a growth company at all IMO. It is a shrinking company most likely with no top line growth, and little ability to extract costs out of the business. If I am right this has something in common with SPO, DSH etc.
I have had very little time to focus on this - so may be missing something very big here - so DYOR and don't rely on my back of the envelope calcs.